Table 2.
Clinical symptom | Patient score (EORTC QLQ-C30)†, mean (95% CI) | Clinician score (NCI-CTCAE)‡, mean (95% CI) |
Pain | 2.31 (2.26 to 2.36) | 2.13 (2.07 to 2.18) |
Fatigue | 2.10 (2.05 to 2.15) | 1.36 (1.33 to 1.40) |
Vomiting | 1.11 (1.08 to 1.14) | 1.18 (1.15 to 1.21) |
Nausea | 1.38 (1.35 to 1.41) | 1.20 (1.16 to 1.24) |
Diarrhea | 1.27 (1.23 to 1.31) | 1.10 (1.08 to 1.12) |
Constipation | 1.50 (1.44 to 1.56) | 1.11 (1.09 to 1.14) |
For purposes of comparison, we considered each of the following pairs to be identical responses: EORTC QLQ-C30 score 1 vs NCI-CTCAE score 0; EORTC QLQ-C30 score 2 vs NCI-CTCAE score 1; EORTC QLQ-C30 score 3 vs NCI-CTCAE score 2; EORTC QLQ-C30 score 4 vs NCI-CTCAE scores 3 and 4 combined. EORTC QLQ-C30 = European Organization for Research and Treatment of Cancer's Quality of Life core questionnaire; NCI-CTCAE = National Cancer Institute's Common Terminology Criteria for Adverse Events.
In the EORTC QLQ-C30 questionnaire, the patient rated his or her symptoms on a 4-point ordinal scale in which a score of 1 meant “not at all,” a score of 2 meant “a little,” a score of 3 meant “quite a bit,” and a score of 4 meant “very much.”
In the NCI-CTCAE scoring, the clinician rated the patient's symptoms on a 5-point scale: a score of 0 meant “none or normal,” a score of 1 meant “mild,” a score of 2 meant “moderate,” a score 3 meant “severe,” and a score of 4 meant “life threatening or disabling.”